Skip to main content
Philip Kuriakose, MD, Oncology, Detroit, MI, Henry Ford Hospital

PhilipKuriakoseMD

Oncology Detroit, MI

Hematologic Oncology

Associate Professor, Internal Medicine, Wayne State University School of Medicine

Dr. Kuriakose is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kuriakose's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1999 - 2002
  • Henry Ford Hospital
    Henry Ford HospitalResidency, Internal Medicine, 1996 - 1999
  • Christian Medical College Ludhiana
    Christian Medical College LudhianaClass of 1990

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1996 - 2027
  • FL State Medical License
    FL State Medical License 1998 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2008-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospecti...
    Philip Kuriakose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Predictors of Transfer to Different Facility at Discharge in Patients Admitted with Hematologic Malignancy: A Nationwide Inpatient Sample (NIS) Database Analysis
    Philip Kuriakose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Breakthrough Hemolysis in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies
    Philip Kuriakose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Professional Memberships

Hospital Affiliations